TTRXTurn Therapeutics Inc.
What is the market doing?
No clear lean: rangebound and a token position.
Choppy, but holding above its 200-day average. Price is +50% vs its 200-day average.
A token position, settled Sep 30, 2026, a few days of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How TTRX is trading
Turn Therapeutics Inc. is +145% over the past year while the S&P 500 is +16%: 129 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +50%
vs 200-day average · a clear uptrend
- RSI (14)
- 32
RSI (14) · neutral
- Below its 52-week high
- 33%
Below its 52-week high
Details›
- Last close2026-10-23
- $10.26
- 1 monthS&P 500 −0.94%
- −23%
- 1 yearS&P 500 +16%
- +145%
- vs 50-day average$11.66
- −12%
- 52-week high
- $15.28
- 52-week low
- $2.71
- Annualised volatility
- 109%
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
Biotechnology
The closest names by size in the same industry